cytori therapeutics inc (CYTX:NASDAQ GM)
E. Carmack Holmes M.D.
Former Director, Cytori Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 52 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. E. Carmack Holmes, MD served as the Surgeon-in-Chief of the University of California Los Angeles (UCLA) Medical Center since 1994 and holds the position of William P. Longmire, Jr. Professor and Chairman of Department of Surgery at UCLA School of Medicine. Dr. Holmes joined UCLA in 1973 and has held professorial positions in the Divisions of Cardiothoracic Surgery and Surgical Oncology for over 30 years. Dr. Holmes served as Vice Chairman of UCLA for five years prior ...
3020 Callan RoadPhone: 858-458-0900
San Diego, California 92121
Board Members Memberships*
University of North Carolina
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Martin M. McGlynn||Chief Executive Officer, Chief Executive Officer of Stemcells California Inc, President of Stemcells California Inc, Director and Member of Strategic Transactions Committee|
|David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.||Chief Executive Officer and Director|
|Martin P. Rosendale||Chief Executive Officer and Director|
Nuo Therapeutics, Inc.
|Bernard A. Hausen M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Chief Medical Officer, Director and Member of Strategic Review Committee|
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|$503.7K||Compensation as of Fiscal Year 2013.|